SpringWorks Therapeutics, Inc. -
Saqib Islam was appointed Chief Executive Officer of SpringWorks Therapeutics in 2018. He was a founding member of the company’s executive team since its launch in 2017 and previously served as Chief Financial Officer and Chief Business Officer of the company. Prior to joining SpringWorks, Saqib was Chief Business Officer at Moderna Therapeutics, where he oversaw critical aspects of the company’s growth, including global strategic planning, corporate development and business development. Prior to Moderna, Saqib served as Executive Vice President, Chief Strategy and Portfolio Officer at Alexion Pharmaceuticals, executing the company’s corporate growth strategies and contributing to its assessment and management of global operations. Saqib has over 25 years of international business management experience and an extensive background in the healthcare banking sector, having held managing director positions in the investment banking divisions of Morgan Stanley and Credit Suisse Securities. He currently serves on the Board of Directors of Passage Bio (where he also serves as a member of its Audit Committee) and Silverback Therapeutics (where he also serves as a member of its Compensation Committee). Saqib received his bachelor’s degree from McGill University, graduating as a Faculty and University Scholar, and a J.D. from Columbia Law School, where he was a Harlan Fiske Stone Scholar.
SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that applies a precision medicine approach to acquiring, developing and commercializing life-changing medicines. We do it to help patients suffering from devastating cancers live longer, better lives.
How? We scrutinize promising molecules from every angle to unlock their full potential. We forge collaborations with industry and academic innovators to multiply the opportunities for success. And we build our company with exceptional people who press beyond Ògood enoughÓ to make a profound impact. In a word, we are tenacious.
We are committed to finding answers people with cancer need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us unlock the full potential of targeted oncology.
Our values guide our actions
We dig deeper and relentlessly search for answers because that’s what the breakthroughs we seek will take. We do it with passion, humility and respect because that’s who we are. These are our values, and they guide us every day.
We take caring very seriously. We care about our patients deeply, intensely and relentlessly. Every day, we care for patients by working harder to develop solutions others haven’t.
Ambition without ego
We exist to ignite the power of promising science to unleash new possibilities for patients. To make this audacious ambition a reality, we must not let personal pride, empty rhetoric, or ego get in the way.
Think deeply, act quickly
Our team is measured, comprehensive, and thoughtful about every move we make, but we’re also driven by a sense of urgency because we know that patients are waiting. We delicately and expertly balance thinking and acting while always upholding our commitment to the highest standards of ethics and integrity.
Good enough is never enough
‘Good enough’ is never enough for the patients and families counting on us. That’s why we constantly push ourselves to become smarter, better, and faster in pursuit of our ambition.
In it together
We’re a team, first and foremost. Each and every SpringWorker is all in with their coworkers, partners, and patients. We do our best work when we all get together, hurling jokes and big ideas, and collectively making it happen. “